Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
other information
Study period:
May 1998
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: well reported GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1998
Report date:
1998

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
yes
Remarks:
3 instead of 5 animals/sex used according to acute-toxic-class-method (OECD 423)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
3 beta,7 beta,15 alpha-Trihydroxy-5-androsten-17-one
EC Number:
617-707-0
Cas Number:
85390-93-8
Molecular formula:
C19 H28 O4
IUPAC Name:
3 beta,7 beta,15 alpha-Trihydroxy-5-androsten-17-one
Details on test material:
- Name of test material (as cited in study report): ZK 91535
- Batch No.: EW320/98A

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female

Administration / exposure

Vehicle:
physiological saline
Duration of exposure:
24 hours
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
no

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.

Any other information on results incl. tables

No compound-related findings were observed in neither clinical observation nor body weight gain nor autopsy.

After administration of ZK 91535 skin discoloration was observed in all animals at the application site. This effect was reversible 48 hours after termination of treatment and was most probably caused by the intensive green color of the compound. No local intolerance reactions (reddening and/or scab formation; swelling) were observed at the application sites .

Applicant's summary and conclusion

Executive summary:

The single dermal administration of the test substance 3 beta,7 beta,15 alpha-Trihydroxy-5-androsten-17-one (ZK 91535) to male and female rats at a dose of 2000 mg/kg was tolerated without any mortality or compound-related clinical or macroscopic pathological signs. The acute dermal toxicity of 3 beta,7 beta,15 alpha-Trihydroxy-5-androsten-17-one in rats is therefore above 2000 mg/kg body weight.

ZK 91535 caused discoloration of the skin at the application site but this effect was reversible within 48 hours and most probably due to the intensive green color of the test compound. No local intolerance reactions at the application sites were observed.